News & Updates

Nirmatrelvir reduces the risk of long COVID

Post-COVID condition, also known as long COVID, is a serious public health problem affecting millions of people around the world.¹

Product Highlight - Cefepime Hydrochloride (Cepiram)

Powder for Injection (vial) 1 g

Death, adverse health outcomes higher for COVID-19 than influenza after hospital admission

With the emergence of new subtypes of respiratory nosocomial infection and multi-drug resistant organisms (MDROs), better surveillance and infection prevention and control are necessary to address these healthcare challenges.

With the emergence of new subtypes of respiratory nosocomial infection and multi-drug resistant organisms (MDROs), better surveillance and infection prevention and control are necessary to address these healthcare challenges. In the MSD-sponsored scientific event entitled “Multidrug Resistant Infections: Updates on Diagnosis and Management” held on July 27, 2023, Dr Evelina Lagamayo, Clinical Pathologist and Microbiologist, Section Chief, Microbiology Department of Clinical Pathology, University of Santo Tomas Hospital; Dr Rontgene Solante, Chair, Adult Infectious Disease, Tropical Medicine, San Lazaro Hospital, and President of the Philippine College of Physicians; and Dr Carmenchu Villavicencio, Infection Control Chair of St. Luke’s Medicla Center Global City, as moderator discussed diagnostic tests for Enterobacterales and Pseudomonas aeruginosa, and the role of ceftolozane/tazobactam (ZERBAXA) in the treatment nosocomial pneumonia.

The future of COVID-19 management: A spotlight on respirology

At the 27th Congress of the Asian Pacific Society of Respirology (APSR) 2023, a Pfizer-sponsored symposium addressed the evolving challenges of COVID-19, particularly for patients with pre-existing respiratory conditions. Chaired by Dr Chan Kwok Wai Adrian, a renowned respiratory physician and intensivist from Mount Elizabeth Novena Hospital, Singapore, and featuring insights from Professor Yang Kuang-Yao of National Yang Ming Chiao Tung University, Taipei, Taiwan, the symposium focused on the disease’s impact, treatment guidelines, regional management strategies, and the role of nirmatrelvir/ritonavir, a new oral combination pill, in the treatment of COVID-19.

Product Highlight - Cepiram

Cefepime HCl Powd for inj 1 g

SARS-CoV-2 Variants: Everything you need to know

The COVID-19 pandemic continues to evolve with the emergence of new SARS-CoV-2 variants. The variants of concern have the potential to impact the transmissibility, virulence, and clinical presentation of the disease, affecting the epidemiology, public health measures, and diagnostic and therapeutic options. Mutations in the spike protein of the virus have increased its ability to infect humans and evade neutralization by natural or immunisation-induced antibodies. The highly mutated Omicron variant of SARS-CoV-2 has multiple sublineages with varying transmissibility and immune evasion potential. Pre-exposure prophylaxis plays a crucial role in protecting the immunocompromised populations against severe disease; however, the rapidly changing landscape of the variants poses a major challenge to the current and future effectiveness of pre-exposure prophylactic monoclonal antibodies.

Product Highlight - CEFUDYNE

Cefuroxime axetil 250 mg/5 mL Powd for oral susp

Product Highlight - AZITHRODYN

Azithromycin 500 mg FC tab

Product Highlight - DYMETRAZOLE

Metronidazole 500 mg tab